Goserelin Acetate with or without Antiandrogen or Estrogen in the Treatment of Patients with Advanced Prostate Cancer: A Multicenter, Randomized, Controlled Trial in Japan

Abstract

Neither short- nor long-term combined androgen blockade had a survival advantage over goserelin acetate alone.